TOKYO BASE Co.,Ltd. (TYO:3415)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions JPY. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Feb 28, 2021
Market Capitalization	23,077	13,736	14,907	18,440	20,642	30,367
Market Cap Growth	-11.26%	-7.85%	-19.16%	-10.67%	-32.02%	69.59%
Enterprise Value	24,288	14,937	15,708	19,758	19,705	30,491
Last Close Price	531.00	319.00	319.87	390.76	435.21	690.53
PE Ratio	26.68	17.70	44.50	-	27.09	-
Forward PE	20.30	16.63	16.11	44.26	44.26	42.25
PS Ratio	1.13	0.68	0.75	0.96	1.09	2.07
PB Ratio	4.59	2.69	2.69	3.44	3.50	9.44
P/TBV Ratio	4.62	2.70	2.71	3.48	3.54	9.63
P/FCF Ratio	-	10.37	20.62	-	-	-
P/OCF Ratio	-	7.88	18.00	288.13	21.43	220.05
PEG Ratio	1.04	2.83	2.83	0.88	0.88	0.88
EV/Sales Ratio	1.19	0.74	0.79	1.03	1.04	2.08
EV/EBITDA Ratio	-	7.63	8.44	14.31	10.93	76.61
EV/EBIT Ratio	14.39	10.14	17.83	91.90	20.27	147.30
EV/FCF Ratio	-	11.27	21.73	-	-	-
Debt / Equity Ratio	0.98	0.77	0.80	0.68	0.54	0.69
Debt / EBITDA Ratio	-	2.02	2.39	2.64	1.78	5.54
Debt / FCF Ratio	-	2.98	6.14	-	-	-
Asset Turnover	1.70	1.73	1.73	1.69	-	1.62
Inventory Turnover	2.65	3.25	3.46	4.04	-	4.39
Quick Ratio	0.88	1.07	1.20	0.82	0.99	1.06
Current Ratio	1.59	1.75	2.01	1.42	1.54	1.58
Return on Equity (ROE)	18.24%	14.59%	6.15%	-9.57%	-	-2.46%
Return on Assets (ROA)	8.81%	7.89%	4.77%	1.18%	-	1.43%
Return on Capital (ROIC)	11.46%	9.68%	5.80%	1.48%	-	1.88%
Return on Capital Employed (ROCE)	23.50%	22.00%	11.70%	3.30%	13.30%	4.90%
Earnings Yield	3.75%	5.65%	2.25%	-2.92%	3.69%	-0.37%
FCF Yield	-	9.65%	4.85%	-3.78%	-0.45%	-1.75%
Dividend Yield	1.21%	1.57%	1.25%	0.51%	-	-
Payout Ratio	-	23.58%	27.16%	-	-	-
Buyback Yield / Dilution	6.26%	5.86%	-1.59%	-0.66%	1.08%	3.71%
Total Shareholder Return	7.49%	7.43%	-0.34%	-0.15%	1.08%	3.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.